A clinical pharmacological study of the potential beneficial effects of a propolis food product as an adjuvant in asthmatic patients

Fundamental and Clinical Pharmacology

Volumn 17, Issue 1, 2003, Pages 93-102

  Khayyal, M T ^a   El Ghazaly, M A ^b   El Khatib, A S ^a,e   Hatem, A M ^c   De Vries, P J F ^d   El Shafei, S ^c   Khattab, M M ^a,e  

^a CAIRO UNIVERSITY   (Egypt)

^b NATIONAL CENTER FOR RADIATION RESEARCH AND TECHNOLOGY   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

^d FRIESLANDCAMPINA   (Netherlands)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Asthma; Cytokines; Propolis; Ventilatory functions

Indexed keywords

ACACETIN; APIGENIN; CHRYSIN; GALANGIN; KAEMPFEROL; NATURAL PRODUCT; PLACEBO; PROPOLIS; QUERCETIN; THEOPHYLLINE;

ADJUVANT THERAPY; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CLINICAL ARTICLE; DIET SUPPLEMENTATION; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATORY CELL; LUNG FUNCTION TEST; MALE; MEDIATOR RELEASE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; VITAL CAPACITY;

ADULT; ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTHMA; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-8; LEUKOTRIENES; MALE; MEDICINE, TRADITIONAL; MIDDLE AGED; MILK; PROPOLIS; RESPIRATORY FUNCTION TESTS;

EID: 0037328998     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-8206.2003.00117.x     Document Type: Article

References (49)

1. Walker P., Crane E. Constituents of propolis. Apidologie (1987) 18 327-334.
2. Volpert R., Elstner E.F. Biochemical activities of propolis extracts. L Standardization and antioxidative properties of ethanolic and aqueous derivatives. Z. Naturforsch. (1993) 48 851-857.
3. Takaisi-Kikuni N.B., Schilcher H. Electron microscopic and microcalorimetric investigations of the possible mechanism of the antibacterial action of a defined propolis provenance. Planta Med. (1994) 60 222-227.
4. Debiaggi M., Tateo F., Pagani L., Luini M., Romero E. Effects of propolis flavonoids on virus infectivity and replication. Microbiologica. (1990) 13 207-213.
5. Amoros M., Lurton E., Boustie J., Girre L., Sauvager F., Cormier M. Comparison of the anti-herpes simplex virus activities of propolis and 3-methyl-but-2-enyl caffeate. J. Nat. Prod. (1994) 57 644-647.
6. 2 spasms. Agents Actions (1982) 10 (Suppl.) 129-134.
7. Khayyal M.T., El-Ghazaly M.A., El-Khatib A.S. Mechanisms involved in the antiinflammatory effect of propolis extract. Drugs Exp. Clin. Res. (1993) 19 197-203.
8. Scheller S., Wilczok T., Imielski S., Krol W., Gabrys J., Shani J. Free radical scavenging by ethanol extract of propolis. Int. J. Rad. Biol. (1990) 57 461-465.
9. El-Ghazaly M.A., Khayyal M.T. The use of aqueous propolis extract against radiation-induced damage. Drugs Exp. Clin. Res. (1995) 21 229-236.
10. Pascual C., Gonzalez R., Torricella R.G. Scavenging action of propolis extract against oxygen radicals. J. Ethnopharmacol. (1994) 41 9-13.
11. National Institutes of Health. Global Strategy for Asthma Management and Prevention. NIH Publication No. 023659. National Heart, Lung, and Blood Institute, NIH, USA. 1998.
12. Barnes P.J. Cytokines as mediators of chronic asthma. Am. J. Respir. Crit. Care Med. (1994) 150 S42-S49.
13. Mattoli S., Mattoso V.L., Solopertro M., Allegra L., Fasoli A. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic non-allergic asthma. J. Allergy Clin. Immunol. (1991) 87 794-802.
14. Broide D.H., Lotz M., Cuomo A.J., Coburn D.A., Federman E.C., Wasserman S.I. Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. (1992) 89 958-967.
15. Dinarello C.A., Ikejima T., Warner S.J.C. et al. Interleukin 1 induces interleukin1. I. Induction of circulating interleukin1 in rabbits in vivo and in human mononuclear cells in vitro. J. Immunol. (1987) 139 1902-1910.
16. Schindler R., Mancilla J., Andres S., Ghorbani R., Clark S.C., Dinarello C.A. Correlation and interactions in the production of interleukin-6 (IL-6), and tumour necrosis factor (TNF) in human blood mononuclear cell: IL-6 suppresses IL-1 and TNF. Blood (1990) 75 40-47.
17. Streiter R.M., Kunkel S.L., Showell H.J. et al. Endothelial cell gene expression of a neutrophil chemotactic factor by TNFα, LPS, and IL-1α. Science (1989) 243 1467-1469.
18. Ohkawara Y., Yamauchi K. Expression of adhesion molecules in bronchial asthma. Nihon Kyobu Shikkan Gakkai Zasshi (1993) 31 125-131.
19. Nakamura Y. Infiltration of inflammatory cells and expression of adhesion molecules in bronchial mucosa of patients with asthma. Nihon Kyobu Shikkan Gakkai Zasshi (1996) 34 1317-1325.
20. Bagnato G., Gulli S., Altavilla D. et al. Circulating adhesion molecules in bronchial asthma. J. Invest. Allergol. Clin. Immunol. (1998) 8 105-108.
21. Bentley A.M., Durham S.R., Robinson D.S. et al. Expression of endothelial and leukocyte adhesion molecules, intercellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthma. J. Allergy Clin. Immunol. (1993) 92 857-868.
22. Van Snick J. Interleukin-6: an overview. Annu. Rev. Immunol. (1990) 8 253-278.
23. Castell J.V., Gomez-Lechon M.J., David M., Hirano T., Kishimoto T., Heinrich P.C. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett. (1988) 232 347-350.
24. Baggiolini M., Walz A., Kunkel S.L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. (1989) 84 1045-1049.
25. Carveth H.J., Bohnsack J.F., McIntyre T.M., Baggiolini M., Prescott S.M., Zimmermann G.A. Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins. Biochem. Biophys. Res. Commun. (1989) 162 387-393.
26. Schröder J.M. The monocyte-derived neutrophil activating peptide (NAP/Interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate. J. Exp. Med. (1989) 170 847-863.
27. Leonard E.J., Skeel A., Yoshimura T., Noer K., Kutvirt S., Van Epps D. Leukocyte specificity and binding of human neutrophil attractant/activation protein-1. J. Immunol. (1990) 144 1323-1330.
28. Bischoff S.C., Baggiolini M., de Weck A.L., Dahinden C.A. Interleukin 8-inhibitor and inducer of histamine and leukotriene release in human basophils. Biochem. Biophys. Res. Commun. (1991) 179 628-633.
29. Kuna P., Reddigari S.R., Kornfeld D., Kaplan A.P. IL-8 inhibits histamine release from human basophils induced by histamine-releasing factors, connective tissue activating peptide III, and IL-3. J. Immunol. (1991) 147 1920-1924.
30. Johrens P.G., Richman-Eisenstat J.B.Y., Housset B.P. et al. Interleukin-8 induces neutrophil accumulation but not protease secretion in the canine trachea. Lung Cell. Mol. Physiol. (1992) 7 L708-L713.
31. Poole S., Cunha F.Q., Selkirk S., Lorenzetti B.B., Ferreira S.H. Cytokine-mediated inflammatory hyper-algesia limited by interleukin-10. Br. J. Pharmacol. (1995) 115 684-688.
32. Fiorentino D.F., Bond M.W., Mosmann T.R. Two types of mouse helper T cell IV Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. (1989) 170 2081-2095.
33. Zlotnik A., Moore K.W. Interleukin-10. Cytokine (1991) 3 366-371.
34. Howard M. O'Garra A. Biological properties of IL-10. Immunol. Today (1992) 13 198-200.
35. Bogdan C., Vodovotz Y., Nathan C. Macrophage deactivation by IL-10. J. Exp. Med. (1991) 174 1549-1555.
36. De Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., Devries J.E. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an auto-regulatory role of IL-10 produced by monocytes. J. Exp. Med. (1991) 174 1209-1220.
37. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. (1991) 147 3815-3822.
38. Oswald I.P., Wynn T.A., Sher A., James S.L. Interleukin-10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor α required as a co-stimulatory factor for interferon γ-induced activation. Proc. Natl Acad. Sci. USA (1992) 89 8676-8680.
39. Chung K.F., Aizawa H., Becker A.B., Frick O., Gold W.M., Nadel J.A. Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY 046) in allergic dogs. Am. Rev. Respir. Dis. (1986) 134 258-261.
40. 2 on allergen-induced asthma. Am. Rev. Respir. Dis. (1993) 148 87-90.
41. 2. Adv. Prostaglandin Thromboxane Res. (1976) 1 461-475.
42. Passargiklian M., Bianco S., Allegra L. et al. Aspects of bronchial reactivity to prostaglandins, and aspirin in asthmatic patients. Respiration (1977) 34 79-91.
43. Noveral J.P., Grunstein M.M. Role and mechanism of thromboxane-induced proliferation of cultured airway smooth muscle cells. Am. J. Physiol. (1992) 263 L555-L561.
44. 2 by cultured bovine airways smooth muscle cells and its inhibition by cyclooxygenase inhibitors. Br. J. Pharmacol. (1994) 111 983-988.
45. Sud'ina G.F., Mirzoeva O.K., Pushkareva M.A., Korshunova G.A., Sumbatyan N.V., Varfolomeev S.D. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett. (1993) 329 21-24.
46. Toda S., Kumura M., Ohnishi M. Effects of phenolcarboxylic acids on superoxide anion and lipid peroxidation induced by superoxide anion. Planta Med. (1991) 57 8-10.
47. Baumann J., Von-Bruchhausen E., Wurm G. Flavanoids and related compounds as inhibitors of arachidonic acid peroxidation. Prostaglandins (1980) 20 627-639.
48. Alcaraz M.J., Hoult J.R.S. Actions of flavonoids and the novel anti-inflammatory flavone, hypolaetin-8-glucoside, on prostaglandin biosynthesis and inactivation. Biochem. Pharmacol. (1985) 34 2477-2482.
49. Lee T.P., Matteliano M.L., Middleton E. Effect of quercetin on human polymorphonuclear leukocyte lysosomal enzyme release and phospholipid metabolism. Life Sci. (1982) 31 2765-2774.